Pamela Rutherford

456 total citations
8 papers, 402 citations indexed

About

Pamela Rutherford is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Pamela Rutherford has authored 8 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Surgery and 3 papers in Immunology. Recurrent topics in Pamela Rutherford's work include Lipoproteins and Cardiovascular Health (3 papers), Cell Adhesion Molecules Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). Pamela Rutherford is often cited by papers focused on Lipoproteins and Cardiovascular Health (3 papers), Cell Adhesion Molecules Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). Pamela Rutherford collaborates with scholars based in United States. Pamela Rutherford's co-authors include Richard M. Schultz, Ronald L. Merriman, Gerald B. Grindey, Sherri L. Andis, John E. Toth, Lee R. Tanzer, Larry W. Hertel, Chris J. Vlahos, Alfred Gallegos and Rosanne Bonjouklian and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Lipid Research.

In The Last Decade

Pamela Rutherford

8 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela Rutherford United States 7 255 115 60 53 42 8 402
Shishinn Sun United States 11 245 1.0× 107 0.9× 67 1.1× 43 0.8× 67 1.6× 15 474
Chiara Soncini Italy 8 352 1.4× 139 1.2× 24 0.4× 45 0.8× 39 0.9× 9 580
Amy M. Delaney United States 7 292 1.1× 90 0.8× 51 0.8× 83 1.6× 26 0.6× 8 441
Heinrich Baust Germany 9 199 0.8× 121 1.1× 29 0.5× 34 0.6× 51 1.2× 11 353
Miaorong She China 10 254 1.0× 118 1.0× 38 0.6× 18 0.3× 48 1.1× 15 389
Marta Stasiak Poland 13 259 1.0× 98 0.9× 76 1.3× 61 1.2× 82 2.0× 19 501
Niko Schmiedeberg Germany 9 200 0.8× 123 1.1× 27 0.5× 45 0.8× 82 2.0× 11 358
Nicole D. Facompre United States 13 227 0.9× 137 1.2× 28 0.5× 43 0.8× 84 2.0× 15 467
Nobuyoshi Tsuruoka Japan 15 354 1.4× 174 1.5× 69 1.1× 21 0.4× 67 1.6× 31 562
Sathyen A. Prabhu United States 9 321 1.3× 94 0.8× 57 0.9× 27 0.5× 69 1.6× 12 454

Countries citing papers authored by Pamela Rutherford

Since Specialization
Citations

This map shows the geographic impact of Pamela Rutherford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Rutherford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Rutherford more than expected).

Fields of papers citing papers by Pamela Rutherford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Rutherford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Rutherford. The network helps show where Pamela Rutherford may publish in the future.

Co-authorship network of co-authors of Pamela Rutherford

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Rutherford. A scholar is included among the top collaborators of Pamela Rutherford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Rutherford. Pamela Rutherford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kuo, Ming‐Shang, John M. Kalbfleisch, Pamela Rutherford, et al.. (2008). Chemical analysis of atherosclerotic plaque cholesterol combined with histology of the same tissue. Journal of Lipid Research. 49(6). 1353–1363. 15 indexed citations
2.
Rekhter, Mark D., Kirk A. Staschke, Thomas Estridge, et al.. (2008). Genetic ablation of IRAK4 kinase activity inhibits vascular lesion formation. Biochemical and Biophysical Research Communications. 367(3). 642–648. 35 indexed citations
3.
Liao, Birong, Eileen McCall, Karen L. Cox, et al.. (2008). Circulating Markers Reflect Both Anti- and Pro-Atherogenic Drug Effects in ApoE-Deficient Mice. Biomarker Insights. 3. BMI.S632–BMI.S632. 1 indexed citations
4.
Rekhter, Mark D., Donetta S. Gifford‐Moore, Xiaodi Huang, et al.. (2007). Immunohistochemical analysis of target proteins of Rho-kinase in a mouse model of accelerated atherosclerosis.. PubMed. 12(4). 169–74. 18 indexed citations
5.
Merriman, Ronald L., Larry W. Hertel, Richard M. Schultz, et al.. (1996). Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models. Investigational New Drugs. 14(3). 243–247. 71 indexed citations
6.
Norman, Bryan H., Chuan Shih, John E. Toth, et al.. (1996). Studies on the Mechanism of Phosphatidylinositol 3-Kinase Inhibition by Wortmannin and Related Analogs. Journal of Medicinal Chemistry. 39(5). 1106–1111. 103 indexed citations
7.
Schultz, Richard M., Ronald L. Merriman, Sherri L. Andis, et al.. (1995). In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin.. PubMed. 15(4). 1135–9. 102 indexed citations
8.
Schultz, Richard M., Ronald L. Merriman, John E. Toth, et al.. (1993). Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenografts.. PubMed. 5(6-7). 223–8. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shishinn Sun Breakdown of academic impact, for papers by Chiara Soncini Breakdown of academic impact, for papers by Amy M. Delaney Breakdown of academic impact, for papers by Heinrich Baust Breakdown of academic impact, for papers by Miaorong She Breakdown of academic impact, for papers by Marta Stasiak Breakdown of academic impact, for papers by Niko Schmiedeberg Breakdown of academic impact, for papers by Nicole D. Facompre Breakdown of academic impact, for papers by Nobuyoshi Tsuruoka Breakdown of academic impact, for papers by Sathyen A. Prabhu
Rankless by CCL
2026